Clinical Trial Update: PRIMADOS Study:A Study of Avastin (Bevacizumab) Plus Docetaxel for First Line Treatment of Patients With Metastatic Breast Cancer [Phase 4]

View source ↗

Summary

This clinical trial update indicates that the Phase 4 PRIMADOS study evaluating Avastin (bevacizumab) plus docetaxel as first-line treatment for metastatic brea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Avastin (bevacizumab)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Breast Cancer | Phase 4 | Status: WITHDRAWN